SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-294635
Filing Date
2018-10-05
Accepted
2018-10-05 16:02:36
Documents
3
Period of Report
2018-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d598701d8ka.htm 8-K/A 29531
2 EX-10.5 d598701dex105.htm EX-10.5 14549
3 EX-10.6 d598701dex106.htm EX-10.6 10535
  Complete submission text file 0001193125-18-294635.txt   56134
Mailing Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503 310-214-0065
EMMAUS LIFE SCIENCES, INC. (Filer) CIK: 0001420031 (see all company filings)

IRS No.: 412254389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-53072 | Film No.: 181110577
SIC: 6770 Blank Checks